The Royal Free London NHS Foundation Trust-The Royal Free Hospital

London NW3 2QG

1 studies enrolling now · 5 studies all time

What they study most

AL Amyloidosis, Malignant Melanoma, Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Primary Systemic (AL) Amyloidosis, Systemic Lupus Erythematosus (SLE)

Studies at this site

• A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants — Recruiting now
• UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma — Completed
• The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis — Stopped early
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis — Completed